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Abstract
Background: In England, two national programmes of HPV vaccination for girls have been instituted, a routine
programme for 12- and 13-year-olds and a catch-up programme for 17- and 18-year-olds. Uptake rates across the
country have been far from uniform, and this research sought to identify factors explaining the variation in uptake
by locality.
Methods: An association between uptake, deprivation and ethnic background had been established in pilot
research. The present analysis was conducted at an aggregate, Primary Care Trust (PCT), level for the first year of
the programmes. Published measures of HPV vaccination uptake, material deprivation, ethnic composition of PCT
populations, primary care quality, and uptake of cervical screening and of other childhood immunisations were
collated. Strong evidence of collinearity amongst the explanatory variables required a factor analysis to be
undertaken. This provided four independent factors, used thereafter in regression models to explain uptake by PCT.
Results: The factor analysis revealed that ethnic composition was associated with attitudes towards cervical
screening and other childhood vaccinations, whilst material deprivation and quality of primary care were
orthogonal. Ethnic composition, early childhood vaccination, cervical screening and primary care quality were
found to be influential in predicting uptake in both the routine and the catch-up cohorts, although with a lower
degree of confidence in the case of the last two independent variables. Lower primary care quality was significant
in explaining a greater fall in vaccination uptake between the first two doses in the catch-up cohort. Greater
deprivation was a significant explanatory factor for both uptake and the fall in uptake between doses for the
catch-up cohort but not for uptake in the routine cohort.
Conclusion: These results for uptake of the first year of the national programme using aggregate data corroborate
findings from intentions surveys and pilot studies. Deprivation, the ethnic composition of the population, the
effectiveness of primary care and the acceptability of childhood vaccinations are salient factors in explaining local
HPV vaccine uptake in England.
Background
Two types of human papillomavirus (HPV), 16 and 18,
have been associated with around 70 per cent of inva-
sive cervical cancers. The virus is transmitted sexually
and prophylactic vaccines appear to be efficacious in
uninfected women [1]. In England, the Joint Committee
on Vaccination and Immunisation [2] evaluated the
available scientific evidence [3] and recommended that
an HPV vaccination protocol be added to the national
childhood immunisation schedule, ostensibly as a cervi-
cal cancer preventative. From September, 2008, it
became routine for girls aged 12 or 13 years to be
offered the bivalent vaccine, Cervarix (GlaxoSmithKlein).
Simultaneously, a “catch-up” vaccination programme
was initiated for older girls, those aged 17 or 18 years.
The arrangements for administering the vaccine across
England were devolved to the local Primary Care Trusts
(PCTs), most of whom followed the Joint Committee’s
recommendation in opting for schools-based delivery of
the routine programme. Data for the first full year of
the scheme indicated that around 88 per cent of girls in
England and eligible as a matter of routine received at
least one dose of the vaccine, although the variation in
uptake by individual PCT was substantial (54 to 100 per
c e n t ) .T h em e a nf i r s t - d o s eu p t a k ei nt h ec a t c h - u p
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by PCT was even greater (8 to 97 per cent) [4]. This
paper reports a search for factors explaining differences
in HPV vaccine uptake by PCT.
Previous studies offer likely contributors to an expla-
nation. The vaccination of children in England is subject
to parental approval and surveys of intent conducted
prior to the programme’s announcement revealed that
most parents knew little about HPV, whilst many were
concerned about sexual health issues that would arise as
a result of a vaccination programme. Acceptability of
daughters’ HPV vaccination was significantly less likely
in non-white households [5,6]. Pilot research in two
PCTs in north-west England, conducted prior to the
implementation of the main programme, revealed lower
uptake in more deprived areas and amongst ethnic min-
ority girls. HPV vaccination was also less likely if other
childhood vaccines had not been received [7,8]. Beyond
the English evidence, previous vaccination history was
predictive of uptake in a Canadian schools programme
[9]. Race, religion and deprivation predicted uptake in a
catch-up campaign in the Netherlands [10]. In the USA,
a study of girls insured through a large managed care
organisation identified higher household income, a
family experience of sexually-transmitted disease, receipt
of other vaccines and mothers’ attendance for cervical
cancer screening as positive predictors of HPV vaccina-
tion [11,12].
Methods
The intention was to construct linear regression models
of uptake for the first 12 months of vaccination, at the
level of the PCT. At the time, there were 152 PCTs cov-
ering England. Throughout the programme’s first year,
the average PCT was responsible for the vaccination of
around 2,000 girls in the routine cohort and slightly
more in the catch-up group. The complete course of
HPV vaccination entailed the administration of three
doses at 0, 1-2 and 6 months. Although uptake data [4]
were nominally available for all three doses, we felt con-
strained to use uptake to the second dose only as the
principal dependent variable. Administrative delays in
some of the PCTs had required the administration of
the third dose beyond the end of study period, implying
that third-dose uptake in those cases was appreciably
under-recorded.
Data were obtained for the following explanatory
variables:
1) Material deprivation, as measured by the Index of
Multiple Deprivation (IMD) for 2007 [13]. The IMD
comprises 38 indicators of poverty and deprivation, each
calculated individually at the level of the “lower super
output area”. England is divided into 32,482 such areas
and deprivation for any PCT is the summary of
deprivation for the output areas which it subsumes.
Four routinely-calculated summary statistics were used:
a) The population-weighted mean of the IMD
scores for each of the output areas within the
PCT. Individual output area scores varied
between approximately zero and 85, with a
higher score indicating greater deprivation.
b) The population-weighted average of the com-
bined ranks of the IMD scores for the output
areas in the PCT (least-deprived output area
ranked 1, and most-deprived ranked 32,482).
c) As a measure of the extent of deprivation, the
proportion of the PCT’s population living in the
10 per cent most deprived output areas in
England.
d) As a measure of the local concentration of
deprivation, the population-weighted average of
t h er a n k so ft h eP C T ’sm o s td e p r i v e do u t p u t
areas which contain exactly 10 per cent of the
PCT’s population.
2) Uptake of routine cytological screening for cervical
pre-cancer by PCT for 2008-9, for two age ranges:
women aged between 25 and 49 years, and those aged
between 50 and 64 years [14]. The uptake of screening
is a measure of women’s attitudes towards cervical can-
cer prevention, and the majority of the mothers of chil-
dren offered HPV vaccination would occupy the
younger age range.
3) Uptake of other vaccines in the national childhood
immunisation schedule in 2008-9, by PCT [15], namely:
a) Diphtheria, tetanus, pertussis, polio and hae-
mophilius influenzae Type B (DTaP/IPV/Hib) at
age 2 years.
b) Measles, mumps, rubella (MMR) and menin-
gitis C (MenC) at age 2 years.
c) Primary doses of diphtheria, tetanus, polio
(DT/IPV) at age 5 years.
d) Booster dose of diphtheria, tetanus, pertussis,
polio (DTaP/IPV) at age 5 years.
e) MMR first dose (MMR1) and second dose
(MMR2) at age 5 years.
4) Prevalence of, and uptake of screening for, other
sexually-transmitted infections, represented by PCT-spe-
cific rates from the national chlamydia screening pro-
gramme for those aged between 15 and 24 years [16].
5) Ethnic/racial identity, as measured by the 2007 eth-
nic composition of the population of each PCT [17].
Proportions were classified as White, Black (African or
Caribbean), Asian (the Indian sub-continent only) and
Other (of which Chinese was the predominant race).
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in primary care, as measured by summary statistics from
the Quality and Outcomes Framework (QOF) for each
PCT. The QOF assesses independently four domains for
each practice, namely, clinical (the management of spe-
cific medical conditions), quality of practice organisa-
tion, quality of patient experience and the delivery of
additional services [18]. Each domain comprises a set of
achievement measures against which practices score
points according to performance, and scores are
expressed as a proportion of the maximum points
achievable.
Given existing research findings, it was anticipated
that there would exist a high degree of collinearity
between the independent variables. It has already been
established, for example, that the parental attitudes and
behaviours which predict receipt of primary vaccines at
an early age predict subsequent vaccinations equally
well [19]. Thus British children un-immunised with pri-
mary vaccines at age 1 are at least ten-times less likely
to be immunised with MMR at age 3 [20]. The uptake
of childhood vaccines has been linked both to depriva-
tion [21,22] and to ethnic composition [23]. Deprivation
and ethnic background appear to condition the uptake
of all forms of cancer screening [24] and have been
associated with cervical screening compliance specifi-
cally in studies conducted in the north-west [25] and in
the north-east [26] of England. The likelihood of having
ever undertaken cervical screening has been shown to
be more than twice as high for White women than for
women of other races [27]. Cervical screening uptake is
a component of the fourth QOF domain (additional ser-
vices) and deprived areas experience lower quality of
care, as assessed by the QOF [28]. Also, deprivation has
been linked to both the coverage and the positive rate
of chlamydia screening [29]. In view of the collinearities,
therefore, a principal components analysis of the expla-
natory variables was undertaken to produce un-corre-
lated factors, and regression models were constructed
from the factor scores of the components identified.
All data used in the analysis were originally compiled
by government or official bodies and are openly avail-
able. All statistical analyses were conducted using SPSS
16.0.
Results
Table 1 displays descriptive statistics for all variables.
For the routine cohort, serial adherence to HPV vacci-
nation across the two doses was high; the average
uptake for the second dose was only 2.3 per cent (SD
3.7) lower than the average uptake for the first.
Table 1 Descriptive statistics for 152 PCTs
Mean Standard
Deviation
Minimum Maximum
Number of girls
eligible
Routine 1,996 1,167 367 7,730
Catch-up 2,181 1,828 654 7,788
HPV uptake, first dose
only, %
Routine 87.6 7.5 54.0 100.0
Catch-up 60.2 16.6 7.6 97.3
HPV uptake, 2 doses,
%
Routine 85.6 8.3 52.1 100.0
Catch-up 52.2 16.3 5.5 95.7
Deprivation
Average IMD
score
23.7 9.1 8.1 48.3
Average rank 17,569 5,340 6,177 28,396
Extent, % 23.9 19.2 0.3 81.3
Local
concentration
29,001 3,055 19,388 32,434
Cervical cancer screening
uptake, %
Ages 25-49 years 72.2 4.7 57.9 81.2
Ages 50-64 years 79.3 3.1 67.8 85.2
Childhood immunisation
uptake, %
DT/IPV, age 5 92.7 6.4 61.5 98.8
DTaP/IPV, age 5 79.8 13.9 21.3 95.2
MMR1, age 5 89.2 5.8 60.2 96.6
MMR2, age 5 78.0 10.8 32.0 91.5
DTaP/IPV/Hib,
age 2
94.0 4.9 64.0 99.4
MMR, age 2 84.9 6.4 56.3 94.7
MenC, age 2 92.0 7.4 56.3 98.8
Chlamydia screening,
%
Screening uptake 16.4 5.1 4.2 35.8
Positive test
results
7.4 2.0 3.5 12.8
Ethnic composition of
population, %
White 86.8 12.7 35.9 97.9
Asian 7.0 7.8 0.9 43.7
Black 4.2 5.2 0.5 24.1
Other 2.1 1.6 0.6 8.8
QOF scores, %
Clinical 97.8 1.3 90.9 99.5
Organisation 95.8 2.7 84.1 99.1
Patient
experience
83.8 6.3 47.2 94.4
Additional
services
97.2 3.2 83.4 100.0
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the corresponding decline in average uptake between
the first two doses was 13.8 per cent (SD 10.2). The
difference in adherences between the cohorts was sig-
nificant (t = 13.6, p < 0.01).
A preliminary factor analysis of the explanatory vari-
ables produced a Kaiser-Meyer-Olkin measure of sam-
pling adequacy of 0.81, thereby confirming the expected
high degree of inter-correlation within the data. All indi-
vidual communalities were ine x c e s so f0 . 6 0 ,w i t ht h e
exception of cervical screening in the higher age range
(0.45) and the uptake of chlamydia screening (0.25).
These two variables were accordingly excluded from the
second stage of data reduction, the results of which
appear in Table 2. The four principal components
explained 81.9 per cent of the total variance. The factor
loadings of the individual components, PC1 through
PC4, indicate very strong correlations within particular
classes of variable, specifically, the four summary statis-
tics for deprivation, the four QOF domains and the
seven uptakes of other childhood vaccines. By way of
interpretation, the factor PC4 evidently represents the
quality of primary care, as assessed by the four QOF cri-
teria. PC2 embodies the four measures of multiple
deprivation which are, in turn, associated with a known
prevalence of a sexually transmitted disease. PC1 is
dominated by the uptake of the other childhood vac-
cines, which are themselves associated with race and
participation in cytological screening. PC3 associates
race with cytological screening attendance and the pre-
valence of sexually transmitted disease. In the two com-
ponents where ethnic variables appear (PCs 1 and 3),
White has the opposite sign to the three non-White eth-
nicities. In themselves, these two components together
explained almost half of the variance in the data.
We constructed regression models explaining two-
dose uptakes for the routine cohort, for the catch-up
cohort and for the proportionate fall in uptake (non-
adherence) between the first and second doses in the
catch-up cohort. Each model employed the factor scores
of the four principal components as independent vari-
ables. In view of the wide variation in numbers eligible
for vaccination by PCT (Table 1), an additional size
variable was included in the models initially, to test for
a scale effect on uptake. For all models, however, the
coefficient on numbers eligible emerged as insignificant
(at p = 0.17 or greater) and the variable was removed.
Table 3 displays the final regression results. PC1 (race/
childhood vaccination/cervical screening) was evidently
influential in explaining all three of the dependent vari-
ables. PC3 (race/screening) and PC4 (primary care qual-
ity) were significant predictors of uptake in both the
routine and the catch-up cohorts, although with a lower
degree of confidence in the case of the last two. Lower
primary care quality (PC4) was significant in explaining
low adherence in the catch-up cohort. PC2 (multiple
deprivation) was a significant explanatory factor for both
uptake and fall in uptake for the catch-up cohort but
not for uptake in the routine cohort.
Table 2 Principal components analysis, varimax rotation,
loadings > 0.4
Communalities PC1 PC2 PC3 PC4
Deprivation
Average IMD score 0.96 0.94
Average rank 0.94 0.92
Extent, % 0.93 0.93
Local concentration 0.83 0.90
Cervical screening, ages 25-
49 year
0.74 0.43 0.55
Childhood immunisation
DT/IPV, age 5 0.82 0.83
DTaP/IPV, age 5 0.88 0.89
MMR1, age 5 0.89 0.92
MMR2, age 5 0.89 0.91
DTaP/IPV/Hib, age 2 0.85 0.89
MMR, age 2 0.87 0.92
MenC, age 2 0.74 0.83
Chlamydia: positive test
results
0.65 0.55 0.56
Ethnic composition
White 0.93 0.42 0.81
Asian 0.82 -0.85
Black 0.79 -0.67 -0.51
Other 0.74 -0.50 -0.62
QOF scores
QOF Clinical 0.58 0.61
QOF Organisation 0.83 0.91
QOF Patient experience 0.66 0.73
QOF Additional services 0.84 0.76
% of variance explained 32.7 19.9 15.4 13.9
Table 3 Regression results
Constant PC1 PC2 PC3 PC4 Adjusted r
2
Uptake at second dose, routine cohort, %
b 85.60 2.48 -0.27 3.11 1.71 0.25
95% CIs 84.45 1.33 -1.42 1.96 0.06
86.75 3.63 0.88 4.26 2.86
Uptake at second dose, catch-up cohort, %
b 52.17 3.07 -2.76 2.27 2.27 0.08
95% CIs 49.67 0.56 -5.27 -0.02 -0.25
54.68 5.59 -0.24 4.79 4.78
Fall in uptake between dose 1 and dose 2, catch-up cohort, %
b 13.75 -1.58 1.82 -1.1 -2.71 0.12
95% CIs 12.22 -3.12 0.28 -2.64 -4.25
15.28 -0.05 3.35 0.44 -1.18
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Ethnicity, deprivation, the quality of primary care and
the uptake of other childhood vaccinations are evidently
salient factors in explaining HPV vaccine uptake at the
PCT level. Our aggregate-data results are consistent
with those of existing survey research based on the
responses of individuals. For example, whilst being more
likely to oppose HPV vaccination in children, Asian
families have been shown to be more supportive than
other non-Whites of other childhood immunisations
[30]. This effect can be observed in PC1. On the other
hand, the loadings in PC3 suggests that Asian families
might well have considered the HPV vaccine in different
terms. In the intention studies, Asian parents were more
likely to cite sex-related concerns, particularly the
potential encouragement of pre-mature or pre-marital
sexual relations, as obstacles to HPV acceptance [6].
Such concerns, possibly fuelled by the print media’s
focus on such matters [31], would not exist in the case
of other childhood vaccines.
The regression analysis reveals that ethnic composi-
tion dominated the explanation of uptake for the rou-
tine cohort and that deprivation became significant only
in relation to the catch-up cohort, where uptake was
considerably lower. It is probable that the mode of
delivery is the root cause of this disparity. For the rou-
tine cohort, 94.2 per cent of eligible girls received vacci-
nations at their schools, yet only 31.4 per cent of girls in
the catch-up cohort did so [4]. Most of the catch-up
girls were vaccinated in primary care (community clinics
or general practice). In a primary care delivery pro-
gramme, conscious efforts on the part of the girls and
their parents need to be made in order to arrange and
secure a vaccination appointment. In contrast, an orga-
nised vaccination programme conducted during normal
school hours reduces the need for personal effort to vir-
tually zero. The decline in serial adherence can be
explained, at least in part, as sequential doses represent-
ing constant costs at falling marginal benefit, although it
appears that such behaviour can be offset, in some
degree, by higher-quality primary care. Whether or not
physicians consider themselves entitled to offer vaccina-
tion in the face of parental disapproval, however,
remains moot [32].
The relatively low coefficients of determination indi-
cate that much of the variation in uptake remains to be
explained, and it is probable that such explanations lie
beyond the scope of aggregate data. For example, the
advantage of a school-operated initiative is logistical
(established channels of information, peer reinforcement
and large numbers of girls in the same place at the
same time). However, absences from school on the
appropriate dates, owing to illness, for example, annul
the method’s advantage. Thus, something as simple and
random as a local influenza epidemic would be enough
to reduce uptake significantly. There are, moreover, rea-
sons why vaccination might be refused over and above
the correlates chosen here. The HPV vaccine is rela-
tively new and long-term efficacy and safety remain to
be established. As a result, projected benefits and harms
from vaccination are subject to considerable uncertainty
[33]. The adoption of mass vaccination has been rapid,
and there may be suspicions that commercial interests
have dominated health concerns in this respect [34].
Reports of adverse side effects, such as pain, swelling,
nausea and light-headedness, might disincline other girls
to attend. In a Scottish implementation study, around
one-quarter of girls reported such side effects, although
the main reasons for declining vaccination were inade-
quate evidence and the lack of any perceived need for
protection, given the existing cytology programme [35].
This study has limitations. First, our measure of vac-
c i n eu p t a k ei sd e f i c i e n ti nt h a ti tp e r t a i n st ot h ef i r s t
two doses only, as opposed to the full course of three
doses. On the one hand, serial adherence in the routine
sample across the first two doses proved to be very
high, and it is tempting to conclude that this pattern
would have continued to completion. On the other, the
lower adherence for the catch-up cohort suggests that
three-dose completion rates are far less easily predicted
from our two-dose uptake rates. This having been said,
it seems improbable that the factors explaining low
adherence across the first two doses would be irrelevant
in explaining similarly-low adherence across all three,
were it to have occurred. This issue will, of course, be
resolvable once subsequent data are collected and pub-
lished. Second, the choice of explanatory variables was
constrained by the non-availability of data mapped to
PCT boundaries, although additional data would prob-
ably assist explanation. A variable for religious affilia-
tion, for example, might better illuminate the character
of the racial differences identified. Third, the QOF
represents, at best, a proxy for organisation quality and
further detail on individualp r a c t i c e sw o u l dd o u b t l e s s
prove enlightening. Finally, it is probable that the aggre-
gate data conceal variation even at the local level. The
average PCT, for example, would be assigned over
twenty separate schools. A low routine uptake figure,
therefore, could be uniform across all the PCT’ss c h o o l s
or caused by especially poor and atypical performances
in a small minority.
Conclusions
Our results indicate that high cervical screening atten-
dances, high uptakes of other childhood vaccinations and
proportionately large White populations pre-disposed
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both routine and catch-up cohorts. Material deprivation,
acting independently of race, was influential in explaining
a lower uptake rate, and a lower serial adherence, for the
catch-up cohort. The quality of primary care was instru-
mental in explaining both uptakes and adherence and
was evidently orthogonal to the other variables. Thus,
there was no evidence to suggest that care quality was
inferior in PCTs recording greater deprivation. Testing
positive for chlamydia negatively influenced uptake when
associated with deprivation but positively influenced
uptake when associated with cervical screening participa-
tion and being White.
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